Haleon Plc Stock Fundamentals
| HLNCF Stock | USD 4.74 0.12 2.60% |
Haleon plc fundamentals help investors to digest information that contributes to Haleon Plc's financial success or failures. It also enables traders to predict the movement of Haleon Pink Sheet. The fundamental analysis module provides a way to measure Haleon Plc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Haleon Plc pink sheet.
Haleon |
Haleon plc Company Current Valuation Analysis
Haleon Plc's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Haleon Plc Current Valuation | 46.45 B |
Most of Haleon Plc's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Haleon plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Haleon plc has a Current Valuation of 46.45 B. This is 223.42% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all United States stocks is 179.43% lower than that of the firm.
Haleon plc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Haleon Plc's current stock value. Our valuation model uses many indicators to compare Haleon Plc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Haleon Plc competition to find correlations between indicators driving Haleon Plc's intrinsic value. More Info.Haleon plc is one of the top stocks in profit margin category among its peers. It is rated # 2 in operating margin category among its peers reporting about 1.53 of Operating Margin per Profit Margin. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Haleon Plc's earnings, one of the primary drivers of an investment's value.Haleon Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Haleon Plc's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Haleon Plc could also be used in its relative valuation, which is a method of valuing Haleon Plc by comparing valuation metrics of similar companies.Haleon Plc is currently under evaluation in current valuation category among its peers.
Haleon Fundamentals
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 46.45 B | |||
| Shares Outstanding | 9.23 B | |||
| Shares Owned By Insiders | 38.54 % | |||
| Shares Owned By Institutions | 26.57 % | |||
| Price To Earning | 17.50 X | |||
| Price To Book | 1.05 X | |||
| Price To Sales | 3.41 X | |||
| Revenue | 9.54 B | |||
| Gross Profit | 5.99 B | |||
| EBITDA | 1.92 B | |||
| Net Income | 1.39 B | |||
| Cash And Equivalents | 1.33 B | |||
| Cash Per Share | 0.14 X | |||
| Total Debt | 10.31 B | |||
| Debt To Equity | 0.38 % | |||
| Current Ratio | 3.43 X | |||
| Book Value Per Share | 2.91 X | |||
| Cash Flow From Operations | 1.36 B | |||
| Earnings Per Share | 0.17 X | |||
| Number Of Employees | 22 K | |||
| Market Capitalization | 36.52 B | |||
| Total Asset | 34.45 B | |||
| Z Score | 1.8 | |||
| Net Asset | 34.45 B |
About Haleon Plc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Haleon plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Haleon Plc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Haleon plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom. Haleon Plc operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 22000 people.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Haleon Pink Sheet
When determining whether Haleon plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Haleon Plc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Haleon Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Haleon Plc Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Haleon plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more detail on how to invest in Haleon Pink Sheet please use our How to Invest in Haleon Plc guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.